Dalektro N Solution/ Drops
NDC Package 59469-305-40
Package Information
Dalektro N (silver nitrate, oyster shell calcium carbonate, crude, cobaltous nitrate hexahydrate, cupric acetate, iron, potassium carbonate, magnesium chloride, manganese acetate tetrahydrate, selenium, silicon dioxide, and zinc phosphide) solution/ dropses is a medication used as Homeopathically processed minerals to help reduce minor stress. This formulation utilizes a solution/ drops delivery system. Marketed by Pekana Natruheilmittel Gmbh, this product is identified by NDC 59469-305.
Identification & Billing
Clinical Specifications
- COBALTOUS NITRATE HEXAHYDRATE 6 [hp_X]/100mL
- CUPRIC ACETATE 12 [hp_X]/100mL
- IRON 6 [hp_X]/100mL
- MAGNESIUM CHLORIDE 4 [hp_X]/100mL
- MANGANESE ACETATE TETRAHYDRATE 8 [hp_X]/100mL
- OYSTER SHELL CALCIUM CARBONATE, CRUDE 6 [hp_X]/100mL
- POTASSIUM CARBONATE 4 [hp_X]/100mL
- SELENIUM 12 [hp_X]/100mL
- SILICON DIOXIDE 12 [hp_X]/100mL
- SILVER NITRATE 6 [hp_X]/100mL
- ZINC PHOSPHIDE 12 [hp_X]/100mL
- Calculi Dissolution Agent - [EPC] (Established Pharmacologic Class)
- Increased Large Intestinal Motility - [PE] (Physiologic Effect)
- Inhibition Large Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Inhibition Small Intestine Fluid/Electrolyte Absorption - [PE] (Physiologic Effect)
- Magnesium Ion Exchange Activity - [MoA] (Mechanism of Action)
- Magnetic Resonance Contrast Activity - [MoA] (Mechanism of Action)
- Osmotic Activity - [MoA] (Mechanism of Action)
- Osmotic Laxative - [EPC] (Established Pharmacologic Class)
- Paramagnetic Contrast Agent - [EPC] (Established Pharmacologic Class)
- Stimulation Large Intestine Fluid/Electrolyte Secretion - [PE] (Physiologic Effect)
Regulatory & Marketing
Hierarchy Structure
- 59469 - Pekana Natruheilmittel Gmbh
- 59469-305 - Dalektro N
- 59469-305-40 - 1 BOTTLE, GLASS in 1 BOX / 100 mL in 1 BOTTLE, GLASS
- 59469-305 - Dalektro N
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (59469-305). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 59469-305-40 identifies a specific commercial package of 1 bottle, glass in 1 box / 100 ml in 1 bottle, glass of Dalektro N, a human over the counter drug labeled by Pekana Natruheilmittel Gmbh. This solution/ drops is formulated for oral use and contains cobaltous nitrate hexahydrate; cupric acetate; iron; magnesium chloride; manganese acetate tetrahydrate; oyster shell calcium carbonate, crude; potassium carbonate; selenium; silicon dioxide; silver nitrate; zinc phosphide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Pekana Natruheilmittel Gmbh on June 24, 2019. The current certification is valid through December 31, 2026.
How is this Pekana Natruheilmittel Gmbh product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 59469030540. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.